StreetInsider.com News Articles

Ryan Specialty Group (RYAN) PT Raised to $34 at Cantor Fitzgerald as Shares Rally

Thu, 09 Jul 2026 07:47:47 -0400

Cantor Fitzgerald analyst Ryan Tunis raised the price target on Ryan Specialty Group (NYSE: RYAN) to $34.00 (from $33.00) while maintaining a Neutral rating.

The analyst commented, "RYAN shares, that had derated below retail broker peers, have rallied over the past month and now trade at a premium. If the company can report a positive organic growth number in the second quarter, one could argue that the premium makes sense (i.e., affirms both soft market and hard market organic growth above retail peers, hence a higher valuation warranted). The problem, in our view, is that it’s not that straightforward. Comparisons will

Ryan Specialty Group (RYAN) PT Raised to $34 at Cantor Fitzgerald as Shares Rally

Thu, 09 Jul 2026 07:47:47 -0400

Cantor Fitzgerald analyst Ryan Tunis raised the price target on Ryan Specialty Group (NYSE: RYAN) to $34.00 (from $33.00) while maintaining a Neutral rating.

Ryan Specialty Group (RYAN) PT Raised to $39 at Mizuho

Thu, 09 Jul 2026 06:44:48 -0400

Mizuho analyst Yaron Kinar raised the price target on Ryan Specialty Group (NYSE: RYAN) to $39.00 (from $35.00) while maintaining a Neutral rating.

Ryan Specialty Group (RYAN) PT Raised to $39 at Wells Fargo

Thu, 09 Jul 2026 06:44:07 -0400

Wells Fargo analyst Elyse Greenspan raised the price target on Ryan Specialty Group (NYSE: RYAN) to $39.00 (from $31.00) while maintaining a Equal Weight rating.

Wolfe Research Downgrades Ryan Specialty Group (RYAN) to Peerperform

Thu, 09 Jul 2026 05:36:16 -0400

(Updated - July 9, 2026 5:36 AM EDT)

Wolfe Research analyst Tracy Benguigui downgraded Ryan Specialty Group (NYSE: RYAN) from Outperform to Peerperform.

The analyst comments "...we downgrade RYAN to PP from OP on full valuation. After the stock is up ~35% since 1Q earnings release, we view the shares as fully valued now (trading ahead of our prior $39 PT) that it is back trading at a premium to its peers (17.8x vs peers at 16.7x). We also see some risks in 2027E street organic growth estimates; we model 5.4% vs Street at 6.4%."

For an analyst ratings summary and ratings history

Wolfe Research Downgrades Ryan Specialty Group (RYAN) to Peerperform

Thu, 09 Jul 2026 05:36:16 -0400

(Updated - July 9, 2026 5:36 AM EDT)

Wolfe Research analyst Tracy Benguigui downgraded Ryan Specialty Group (NYSE: RYAN) from Outperform to Peerperform.

For an analyst ratings summary and ratings history

Ryan Specialty Group (RYAN) PT Lowered to $50 at UBS

Wed, 08 Jul 2026 09:14:27 -0400

UBS analyst Brian Mereditch lowered the price target on Ryan Specialty Group (NYSE: RYAN) to $50.00 (from $52.00) while maintaining a Buy rating.

Ryan Specialty Group (RYAN) PT Raised to $42 at Morgan Stanley

Mon, 06 Jul 2026 08:01:21 -0400

Morgan Stanley analyst Bob Huang raised the price target on Ryan Specialty Group (NYSE: RYAN) to $42.00 (from $39.00) while maintaining a Overweight rating.

Ryan Specialty Underwriting Managers Completes a Series of Lloyd’s Consortium Stamps to Support its Delegated Portfolio